Macrophages, PPARs, and Cancer
Author Information
Author(s): Jo A. Van Ginderachter, Kiavash Movahedi, Jan Van den Bossche, Patrick De Baetselier
Primary Institution: Laboratory of Cellular and Molecular Immunology, VIB and Vrije Universiteit Brussel, Belgium
Hypothesis
The study investigates the role of peroxisome proliferator-activated receptors (PPARs) in macrophage activation and their implications in cancer.
Conclusion
Current knowledge supports the clinical evaluation of PPAR ligands as potential chemopreventive agents in cancer development associated with chronic inflammation.
Supporting Evidence
- Macrophages can switch between pro-inflammatory and anti-inflammatory states.
- PPARs are involved in regulating macrophage functions and their response to inflammation.
- PPAR ligands may inhibit tumor-promoting factors produced by macrophages.
Takeaway
Macrophages can help or hurt cancer growth, and certain drugs that affect them might help prevent cancer.
Limitations
The complexity of macrophage responses and the variability in their activation states complicate the prediction of outcomes from PPAR agonism.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website